Eli Lilly and Co. plans to pay up to $500 million to fellow drugmaker AstraZeneca as part of a collaboration to develop and sell a potential Alzheimer's disease treatment that is in the early stages of clinical testing.
20 hours ago
4 / 5 (1) | 0
Nearly three in 10 former NFL players will develop at least moderate neurocognitive problems and qualify for payments under the proposed $765 million concussion settlement, according to data prepared for ex-players' lawyers ...
Sep 12, 2014
not rated yet | 0